Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Efficacy and Modulating Factors of Repetitive Transcranial Magnetic Stimulation on Motor Function in Parkinson's Disease: A Meta-Analysis.

Physiotherapy research international : the journal for researchers and clinicians in physical therapy·2026
Same author

Decomposition-based harmonization for quantitative PET imaging across scanners and radiotracers.

Medical physics·2026
Same author

Multimodal neuroimaging elucidates the posterior-to-anterior gradient of nigrostriatal degeneration in Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

An exploratory <sup>18</sup>F-Florzolotau tau PET study in putative body-first versus brain-first Parkinson's disease.

European journal of nuclear medicine and molecular imaging·2026
Same author

Knowledge Graph Augmented Large Language Models for Disease Prediction.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

ClinNoteAgents: An LLM Multi-Agent System for Predicting and Interpreting Heart Failure 30-Day Readmission from Clinical Notes.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
関連記事をすべて見る

関連する実験動画

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

バイオマーカー

Mei Cui1,2, Jiawei Xin3, Yu Guo2

  • 1MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
まとめ
この要約は機械生成です。

18F-フロルゾロタウPETイメージングは、認知障害のある患者におけるアルツハイマー病を含むタウオパチーを正確に検出します。この高度なイメージングは、記憶クリニックにおける診断精度と信頼性を大幅に向上させます。

キーワード:
18F-フロルゾロタウPETタウオパチーアルツハイマー病診断精度記憶クリニック

さらに関連する動画

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

関連する実験動画

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学分野:

  • 神経学、核医学、放射線化学

背景:

  • 未選択の記憶クリニック患者における18F-フロルゾロタウPETの臨床的有用性は不明です。本研究では、認知障害の診断精度、再分類への影響、および信頼性に対する18F-フロルゾロタウPETの評価を行います。

研究 の 目的:

  • 実際の記憶クリニックの設定における18F-フロルゾロタウPETの診断パフォーマンスを評価すること。認知状態全体にわたる診断再分類と信頼性に対する18F-フロルゾロタウPETの影響を決定すること。

主な方法:

  • 認知障害のある患者838人を対象としたコホート研究。患者はアミロイドPETと18F-フロルゾロタウPETスキャンの両方を受けました。PET所見と最終的な臨床診断との比較。

主要な成果:

  • 18F-フロルゾロタウPETは、一次（80-75％）および二次（95.7％）タウオパチーに対して高い精度を示し、アルツハイマー病に対しては98.2％の感度と96.7％の特異度を示しました。主観的認知機能低下群（36.8％）および軽度認知障害群（30.6％）では、診断再分類率が高くなりました。18F-フロルゾロタウPET後の診断信頼度は、68.6％から84.2％へと有意に増加しました。

結論:

  • 18F-フロルゾロタウPETは、タウオパチーの早期かつ正確な検出に大きな可能性を示しています。18F-フロルゾロタウPETの統合は、認知障害に対する記憶クリニックにおける診断ワークフローを強化できます。